Technology News and Research

RSS

Onset Therapeutics expands sales force by over 50% in 2010

Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today announced the completion of the Company's latest sales force expansion initiative designed to provide national dermatology coverage to support the success of two recently launched products and the Company's rapidly growing pipeline of products in various stages of development.

10 Jun 2010

FDA grants Collegium Fast Track designation for COL-172 opioid formulation

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.

10 Jun 2010

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.

10 Jun 2010

StemCells' GS2-M cell culture media formulation enhances pluripotency of human ES, iPS cells

StemCells, Inc. announced today that newly published independent research demonstrates that its GS2-M cell culture media formulation enhances the pluripotency of human embryonic stem and induced pluripotent stem cells. The Company's GS2-M medium has already been shown to enable the derivation and long-term maintenance of mouse iPS cells.

10 Jun 2010

Elsevier announces acquisition of Collexis

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.

10 Jun 2010

PURE Bioscience's anhydrous SDC technology granted US patent

PURE Bioscience today announced that the United States Patent and Trademark Office issued patent number 7,732,486, which covers PURE's anhydrous silver dihydrogen citrate technology.

10 Jun 2010

PAREXEL experts to present on biopharmaceutical industry issues at 46th DIA

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that several of its experts will present on important industry issues at the Drug Information Association (DIA) 46th Annual Meeting, being held from June 13 – 17, 2010 in Washington, DC.

From Parexel 10 Jun 2010

NanoString Technologies launches new solution to detect CNVs in human genomic samples

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the launch of its early access program for a unique new solution that detects copy number variation in human genomic samples. The program was announced in conjunction with the company's participation in the European Human Genetics Conference in Gothenburg, Sweden.

From NanoString Technologies 10 Jun 2010

Nativis awarded patents in Japan, China, India for drug signal technology

Nativis, Inc., a La Jolla, Calif.-based life science company, has been issued patents in Japan, China and India for its innovative technology that captures the unique signals of approved drugs at the atomic level and then delivers the signal in a solution to treat serious illnesses. The technology, which also has U.S., Canadian and Australian patents, promises to transform the treatment of diseases, including those for which there are no known cures, such as brain cancer.

10 Jun 2010

Periogenix to be introduced at International Symposium for Periodontics & Restorative Dentistry

OroScience plc (Palo Alto, CA), in conjunction with Ace Surgical Supply, Inc. (Brockton, MA), will be exhibiting and introducing Periogenix at the 10th International Symposium for Periodontics & Restorative Dentistry in Boston, Massachusetts from June 10th to 12th, 2010. Sponsored by the International Quintessence Publishing Group, publisher of The International Journal of Periodontics & Restorative Dentistry, and the American Academy of Periodontology, this symposium addresses current trends in periodontal surgery and implant and esthetic dentistry.

10 Jun 2010

2010 Independence Expo to promote active living and independence for aged and disabled Americans

United Spinal Association presents the 2010 Independence Expo – Long Island, the region's premier lifestyle-enhancing Expo designed to promote active living and independence for all people with disabilities and aging Americans.

10 Jun 2010

Brain stimulation with ultrasound may enhance cognitive function

The ability to diagnose and treat brain dysfunction without surgery, may rely on a new method of noninvasive brain stimulation using pulsed ultrasound developed by a team of scientists led by William "Jamie" Tyler, a neuroscientist at Arizona State University. The approach, published in the journal Neuron on June 9, shows that pulsed ultrasound not only stimulates action potentials in intact motor cortex in mice but it also "elicits motor responses comparable to those only previously achieved with implanted electrodes and related techniques," says Yusuf Tufail, the lead author from ASU's School of Life Sciences.

10 Jun 2010

LAB Research completes development of novel drug investigation model

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that it has recently completed development of a novel drug investigation model focused on biodistribution and pharmacokinetic of biologics.

10 Jun 2010

Clarient becomes preferred genetic testing lab for Generation Health

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.

10 Jun 2010

TeleHealth Services announces new partnership with Desoto Memorial Hospital

TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education systems, today announced a new partnership with Desoto Memorial Hospital. The Arcadia, Florida based acute care facility chose TeleHealth Services as its interactive patient education provider because of the new functionality of the TIGR technology, custom financing options, and excellent service history in the facility.

10 Jun 2010

Spectrum Dynamics commences ultra low dose trials of radiopharmaceutical agents with D-SPECT technology

Cardiovascular imaging accounts for 30 percent of all the radiation patients receive in the U.S. and today, at the Society for Nuclear Medicine annual meeting, Spectrum Dynamics announced it has begun clinical studies to show that its D-SPECT™ technology can accommodate significantly lower doses of radiopharmaceutical agents so the total radiation exposure to patients and staff is much lower compared to conventional cardiac imaging.

10 Jun 2010

MonoSol Rx, APR expand film formulation development collaboration

MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.

10 Jun 2010

Driving while distracted is equivalent to drunken driving

It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.

10 Jun 2010

Today's multi-touch systems may lead people to MSD: Researchers

The evolution of computer systems has freed us from keyboards and now is focusing on multi-touch systems, those finger flicking, intuitive and easy to learn computer manipulations that speed the use of any electronic device from cell phones to iPads. But little is known about the long-term stresses on our bodies through the use of these systems.

10 Jun 2010

Texas Tech signs worldwide license agreement for metallo-beta-lactamase inhibitors with RI Scientific

Officials at Texas Tech University System's Office of Technology Commercialization announced Wednesday (June 9) the signing of an exclusive worldwide license agreement for a chemical additive called an aptamer that makes certain existing antibiotics viable against antibiotic-resistant bacteria.

10 Jun 2010

Technology News and Research

Onset Therapeutics expands sales force by over 50% in 2010

FDA grants Collegium Fast Track designation for COL-172 opioid formulation

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

StemCells' GS2-M cell culture media formulation enhances pluripotency of human ES, iPS cells

Elsevier announces acquisition of Collexis

PURE Bioscience's anhydrous SDC technology granted US patent

PAREXEL experts to present on biopharmaceutical industry issues at 46th DIA

NanoString Technologies launches new solution to detect CNVs in human genomic samples

Nativis awarded patents in Japan, China, India for drug signal technology

Periogenix to be introduced at International Symposium for Periodontics & Restorative Dentistry

2010 Independence Expo to promote active living and independence for aged and disabled Americans

Brain stimulation with ultrasound may enhance cognitive function

LAB Research completes development of novel drug investigation model

Clarient becomes preferred genetic testing lab for Generation Health

TeleHealth Services announces new partnership with Desoto Memorial Hospital

Spectrum Dynamics commences ultra low dose trials of radiopharmaceutical agents with D-SPECT technology

MonoSol Rx, APR expand film formulation development collaboration

Driving while distracted is equivalent to drunken driving

Today's multi-touch systems may lead people to MSD: Researchers

Texas Tech signs worldwide license agreement for metallo-beta-lactamase inhibitors with RI Scientific

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News